In vitro characterization of parasympathetic and sympathetic responses in cyclophosphamide-induced cystitis in the rat

Basic and Clinical Pharmacology and Toxicology

Volumn 100, Issue 2, 2007, Pages 96-108

  Giglio, Daniel ^a   Aronsson, Patrik ^a   Eriksson, Leif ^a   Tobin, Gunnar ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBACHOL; CYCLOPHOSPHAMIDE; ISOPRENALINE; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENTOLAMINE; PIRENZEPINE; POTASSIUM; PROPRANOLOL; SURAMIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYSTITIS; DESENSITIZATION; DETRUSOR MUSCLE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ELECTRIC FIELD; ELECTROSTIMULATION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CYCLOPHOSPHAMIDE; CYSTITIS; DIAMINES; ELECTRIC STIMULATION; MALE; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; PARASYMPATHOLYTICS; PHENTOLAMINE; PIPERIDINES; PIRENZEPINE; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; SURAMIN; SYMPATHOLYTICS; URINARY BLADDER;

RATTUS;

EID: 33846423529     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00014.x     Document Type: Article

References (45)

1. Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 2004;84:935-86.
2. Brading AF, Williams JH. Contractile responses of smooth muscle strips from rat and guinea-pig urinary bladder to transmural stimulation: effects of atropine and α,β-methylene ATP. Br J Pharmacol 1990;99:493-8.
3. Langley JN, Anderson HK. The innervation of the pelvic and adjoining viscera. Part II. The bladder. J Physiol (London) 1895;19:71-84.
4. Burnstock G. A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L (eds). Cell Membrane Receptors for Drugs and Hormones: a Multidisciplinary Approach. Raven Press, New York, 1978, pp. 107-18.
5. Burnstock G. Purinergic nerves and receptors. Prog Biochem Pharmacol 1980;16:141-54.
6. Burnstock G, Dumsday B, Smythe A. Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol 1972;44:451-61.
7. Dean DM, Downie JW. Contribution of adrenergic and 'purinergic' neurotransmission to contraction in rabbit detrusor. J Pharmacol Exp Ther 1978;207:431-45.
8. 2+-permeable channel activated by ATP in smooth muscle. Nature 1987;328:275-8.
9. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 1985;16:433-40.
10. Inoue R, Brading AF. The properties of the ATP-induced depolarization and current in single cells isolated from the guinea-pig urinary bladder. Br J Pharmacol 1990;100:619-25.
11. Kinder RB, Mundy AR. Atropine blockade of nerve-mediated stimulation of the human detrusor. Br J Urol 1985;57:418-21.
12. Sibley GN. A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol 1984;354:431-43.
13. Tagliani M, Candura SM, Di Nucci A et al. A re-appraisal of the nature of the atropine-resistant contraction to electrical field stimulation in the human isolated detrusor muscle. Naunyn Schmiedebergs Arch Pharmacol 1997;356:750-5.
14. Yoshida M, Homma Y, Inadome A et al. Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles. Exp Gerontol 2001;36:99-109.
15. Palea S, Artibani W, Ostardo E, Trist DG, Pietra C. Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J Urol 1993;150:2007-12.
16. Saito M, Kondo A, Kato T, Miyake K. [Response of the human neurogenic bladder induced by intramural nerve stimulation]. Nippon Hinyokika Gakkai Zasshi 1993;84:507-13. (in Japanese)
17. Sjogren C, Andersson KE, Husted S, Mattiasson A, Moller-Madsen B. Atropine resistance of transmurally stimulated isolated human bladder muscle. J Urol 1982;128:1368-71.
18. Mok MH, Knight GE, Andrews PL, Hoyle CH, Burnstock G. The effects of cyclophosphamide on neurotransmission in the urinary bladder of Suncus murinus, the house musk shrew. J Auton Nerv Syst 2000;80:130-6.
19. Yoshimura N, de Groat WC. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci 1999;19:4644-53.
20. Birder LA, Ruan HZ, Chopra B et al. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol Renal Physiol 2004;287:F1084-91.
21. Giglio D, Ryberg AT, To K, Delbro DS, Tobin G. Altered muscarinic receptor subtype expression and functional responses in cyclophosphamide induced cystitis in rats. Auton Neurosci 2005;122:9-20.
22. Hammer R, Berrie CP, Birdsall NJ, Burgen AS, Hulme EC. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 1980;283:90-2.
23. Melchiorre C, Angeli P, Lambrecht G, Mutschler E, Picchio MT, Wess J. Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine. Eur J Pharmacol 1987;144:117-24.
24. Barlow RB, Shepherd MK. A further search for selective antagonists at M2-muscarinic receptors. Br J Pharmacol 1986;89:837-43.
25. Eglen RM, Nahorski SR. The muscarinic M(5) receptor: a silent or emerging subtype? Br J Pharmacol 2000;130:13-21.
26. Kasakov L, Burnstock G. The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol 1982;86:291-4.
27. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998;50:413-92.
28. Lambrecht G. Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol 2000;362:340-50.
29. Cox PJ. Cyclophosphamide cystitis - identification of acrolein as the causative agent. Biochem Pharmacol 1979;28:2045-9.
30. Giglio D, Delbro DS, Tobin G. On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder. Eur J Pharmacol 2001;428:357-64.
31. Brading AF, Mostwin JL. Electrical and mechanical responses of guinea-pig bladder muscle to nerve stimulation. Br J Pharmacol 1989;98:1083-90.
32. Peterson JS, Noronha-Blob L. Effects of selective cholinergic antagonists and α,β-methylene ATP on guinea-pig urinary bladder contractions in vivo following pelvic nerve stimulation. J Auton Pharmacol 1989;9:303-13.
33. Hegde SS, Choppin A, Bonhaus D et al. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br J Pharmacol 1997;120:1409-18.
34. Giglio D, Delbro DS, Tobin G. Postjunctional modulation by muscarinic M2 receptors of responses to electrical field stimulation of rat detrusor muscle preparations. Auton Autacoid Pharmacol 2005;25:113-20.
35. Somogyi GT, Tanowitz M, de Groat WC. M1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder. J Physiol 1994;480(Pt. 1), 81-9.
36. Tobin G, Sjogren C. In vivo and in vitro effects of muscarinic receptor antagonists on contractions and release of [3H]acetylcholine in the rabbit urinary bladder. Eur J Pharmacol 1995;281:1-8.
37. Somogyi GT, Zernova GV, Yoshiyama M, Rocha JN, Smith CP, de Groat WC. Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury. Neurochem Int 2003;43:73-7.
38. Seguchi H, Nishimura J, Zhou Y, Niiro N, Kumazawa J, Kanaide H. Expression of β3-adrenoceptors in rat detrusor smooth muscle. J Urol 1998;159:2197-201.
39. Oshita M, Hiraoka Y, Watanabe Y. Characterization of β-adrenoceptors in urinary bladder: comparison between rat and rabbit. Br J Pharmacol 1997;122:1720-4.
40. Longhurst PA, Levendusky M. Pharmacological characterization of β-adrenoceptors mediating relaxation of the rat urinary bladder in vitro. Br J Pharmacol 1999;127:1744-50.
41. Hopkinson HE, Latif ML, Hill SJ. Non-competitive antagonism of β(2)-agonist-mediated cyclic AMP accumulation by ICI 118551 in BC3H1 cells endogenously expressing constitutively active β(2)-adrenoceptors. Br J Pharmacol 2000;131:124-30.
42. Popp BD, Hutchinson DS, Evans BA, Summers RJ. Stereo-selectivity for interactions of agonists and antagonists at mouse, rat and human β3-adrenoceptors. Eur J Pharmacol 2004;484:323-31.
43. Tobin G, Sjogren C. Prejunctional facilitatory and inhibitory modulation of parasympathetic nerve transmission in the rabbit urinary bladder. J Auton Nerv Syst 1998;68:153-6.
44. Zhang XY, Olszewski MA, Robinson NE. Beta 2-adrenoceptor activation augments acetylcholine release from tracheal parasympathetic nerves. Am J Physiol 1995;268:L950-6.
45. Oh SJ, Paick SH, Lim DJ, Lee E, Lee SE. Effects of local anesthetics on human bladder contractility. Neurourol Urodyn 2005;24:288-94.